MNKD · Mannkind Corp · Investor Relations
$3.06
-0.03 (-0.92%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$993.56M
Shares
321.54M
Volume · Oct 19
2.46M
Avg daily vol (3M)
4.5M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-10-20 18:00 UTC | Chardan Healthcare Conference | Conference |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-15 | H.C. Wainwright 28th Annual Global Investment Conference | Conference |
| 2026-09-10 | Cantor Global Healthcare Conference | Conference |
| 2026-08-05 | Q2 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-07-29 | INFLO‑1 Data Readout: Strengthening the Nintedanib DPI Opportunity in IPF | Webcast |
| 2026-07-24 | U.S. FDA Approval of Furoscix ReadyFlow Autoinjector | Webcast |
| 2026-06-03 | Jefferies Global Healthcare Conference 2026 | Conference |
| 2026-05-29 | U.S. FDA Approval of Afrezza in Pediatrics | Webcast |
| 2026-05-06 | MannKind Corporation Q1 2026 Earnings Call | Earnings call |
| 2026-02-26 | Q4 Earnings conference call (announced in 8-K) | Earnings call |
Key facts
CIK
899460
CUSIP
56400P706
13F (30d)
22 filings
21 filers
Visit website
Investor relations